Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Meet the top billionaires of the healthcare industry

Bloomberg ranked the 500 richest people in the world in its Bloomberg Billionaires Index, with several healthcare names making the list.

 

Thumbnail

Coronavirus spreads from China to US

A new virus that presents with SARS-like symptoms has been discovered in China and already spread to at least two people in the United States, according to the CDC.

Thumbnail

Pharma industry lobbying hit $29M in 2019

The pharmaceutical industry upped its lobbying efforts in 2019, with a record-high of $29 million spent lobbying Congress.

Thumbnail

Civica Rx, Blue Cross Blue Shield tackle high-cost generic medications with new subsidiary

Civica Rx and the Blue Cross Blue Shield Association and 18 of its health plans have teamed up to create a new subsidiary that will target low-cost generic drugs.

Thumbnail

How US could fall behind China in AI development

The United States is still viewed as the world’s leader in researching and developing AI solutions—but could that reputation be at stake?

Thumbnail

$13.3B of healthcare administration could be automated

One-third of healthcare administrative spending could be automated and save $13.3 billion, according to a report by CAQH.

Thumbnail

Centene, WellCare $17.3B merger clears regulatory requirements

Centene has passed all regulatory hurdles to seal the deal on a merger with WellCare Health Plans worth $17.3 billion.

Thumbnail

Partnership aims to bring AI imaging solutions to Africa

Oxipit, a Lithuania-based medical imaging solutions manufacturer, and Healthcare Konnect, a Swiss distribution company, have announced a new partnership focused on delivering AI imaging solutions to Nigeria.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.